AlphaCrest Capital Management’s Dentsply Sirona XRAY Stock Holding History

AlphaCrest Capital Management’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-59,981	Closed	-$1.7M	–	1166
2022 Q3	$1.7M	Sell	59,981 -33,746	-36%	-$1.15M	0.1%	289
2022 Q2	$3.35M	Sell	93,727 -22,084	-19%	-$893K	0.16%	140
2022 Q1	$5.7M	Buy	115,811 +50,796	+78%	+$2.69M	0.32%	38
2021 Q4	$3.63M	Buy	65,015 +31,171	+92%	+$1.71M	0.13%	162
2021 Q3	$1.97M	Sell	33,844 -11,216	-25%	-$691K	0.1%	310
2021 Q2	$2.85M	Buy	45,060 +30,721	+214%	+$2.02M	0.12%	232
2021 Q1	$915K	Sell	14,339 -1,711	-11%	-$99.2K	0.05%	536
2020 Q4	$840K	Buy	16,050 +488	+3%	+$24.1K	0.07%	385
2020 Q3	$681K	Buy	+15,562	New	+$688K	0.07%	421
2020 Q2	–	Sell	-39,258	Closed	-$1.52M	–	1153
2020 Q1	$1.52M	Sell	39,258 -15,728	-29%	-$801K	0.18%	137
2019 Q4	$3.11M	Buy	+54,986	New	+$3.07M	0.26%	56
2019 Q2	–	Sell	-4,902	Closed	-$243K	–	1152
2019 Q1	$243K	Buy	+4,902	New	+$216K	0.04%	724

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AlphaCrest Capital Management's XRAY Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Dentsply Sirona (XRAY) in Q4 2022, closing a stake of 59,981 shares — an estimated $1.7M sold.

AlphaCrest Capital Management first reported a position in XRAY in Q1 2019 and held it in 12 quarters. The position peaked at $5.7M in Q1 2022. 437 funds tracked by Wall St. Rank hold XRAY as of Q4 2022.

AlphaCrest Capital Management reported no remaining Dentsply Sirona position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 59,981 Dentsply Sirona shares in Q4 2022, an estimated $1.7M.
AlphaCrest Capital Management first reported a position in Dentsply Sirona in Q1 2019 and held it in 12 quarters.
AlphaCrest Capital Management's Dentsply Sirona position peaked at $5.7M in Q1 2022.
437 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.